Privacy Policy
Signals Blog

Contributors

Categories

Stifling Science?

  On June 18, 2014, I walked into the enormous, blue lit plenary hall of the Vancouver Convention Centre excited to hear Canada’s own Janet Rossant give the opening remarks for ISSCR’s Presidential Symposium. I glanced up at the information screens and read, to...

Highlights from The Business of Regenerative Medicine Course

. The Centre for Commercialization of Regenerative Medicine (CCRM) just finished hosting the 7th annual Business of Regenerative Medicine course here in Toronto, which saw many notable figures in the space come to weigh-in on a number of critical issues relevant to...

Update from the Clinic: June

. Welcome to your Update from the Clinic for the month of June. Neuralstem presented final data on a first-in-class drug for the treatment of major depressive disorder, which is proving to be an effective and non-invasive means to boost brain volume. OncoMed has a...

Tips from the grad school trenches on launching a career

> Anyone who has, or is working on, a graduate degree (e.g. PhD, MSc) has likely encountered the “what does a PhD/MSc get you?” question. In my experience, the most frustrating thing wasn’t that I was asked this question at least three times at every family...

Right Turn: Wherefore art thou stem cell artists?

.. CCRM’s intrepid communications summer student is back! Erin Sugar dishes on the intersection between health, art and science using an intriguing medium: the Petri plate. In the spirit of the return of the Cells I See art contest (submissions begin mid-July, 2014 –...

Careful with the heart strings: Promise vs. potential

> The cellular therapy plenary at the ISSCR conference on June 19 was an incredibly interesting mix of hope and despair. On one hand, the opening talk by Leigh Turner made us imagine thousands of people in the United States getting duped into stem cell therapies as...